Cencora controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile6 entries
2024
Cyber incident involving patient information
Cencora disclosed a cyber incident in which patient information was exposed.
2022
Opioid distribution litigation
AmerisourceBergen faced lawsuits alleging that its distribution of prescription opioids contributed to the United States opioid crisis. It joined other distributors in a broad settlement framework while not admitting wrongdoing.
2021
New York reaches $1.1 billion opioid settlement with distributors
Settlement
New York agreed to a $1.1 billion settlement with Cardinal Health, McKesson and AmerisourceBergen over claims that they helped fuel the opioid epidemic. The agreement requires the distributors to create a clearinghouse of opioid shipments to help flag suspicious orders.
Source excerpt
The agreement also requires the distributors to create a clearinghouse of their opioid shipments to help flag suspicious orders.
New York has agreed to a $1.1 billion settlement with three of the nation’s largest drug distributors — Cardinal Health, McKesson and Amerisource Bergen — over claims they helped fuel the opioid epidemic.
2020
Oklahoma sues opioid distributors
Lawsuit filed
Oklahoma Attorney General Mike Hunter filed a lawsuit against Cardinal Health, McKesson and AmerisourceBergen, alleging that the companies distributed an oversupply of opioids into Oklahoma. The report states that the companies' liability is alleged, not established. The event is recorded as a controversy note concerning Cencora, formerly known as AmerisourceBergen, based on the reported filing and the source quote.
Company response
Denial — McKesson
McKesson said in a statement Monday that “any suggestion that (the company) drove demand for opioids in this country reflects a fundamental misunderstanding and mischaracterization of our role as a distributor.”
Source excerpt
Oklahoma Attorney General Mike Hunter on Monday brought a lawsuit against three distributors of opioids
Hunter filed the lawsuit in Cleveland County District Court against Cardinal Health Inc., McKesson Corp. and AmerisourceBergen Corp.
The lawsuit said the defendants “distributed what can only be called a major oversupply of opioids into Oklahoma.”
2019
Encinitas sues opioid manufacturers and distributors
Lawsuit filed
In 2019, the city of Encinitas filed a lawsuit against multiple companies and parties in the opioid industry. The suit alleged that manufacturers and distributors engaged in conduct that led doctors to prescribe opioids and neglected to warn consumers about their addictiveness. The lawsuit named Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., AmerisourceBergen Corp., and Purdue Pharma's owners, the Sackler family. The filing is recorded as a controversy involving AmerisourceBergen Corp., now known as Cencora.
Stated objective. Recover costs and tax resources taken from the city and its citizens due to the opioid crisis.
Source excerpt
The parties named in the suit include Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., the AmerisourceBergen Corp. and the Sackler family, the owners of oxycontin manufacturer Purdue Pharma.
The city of Encinitas announced Thursday that it filed a lawsuit against multiple companies and parties in the opioid manufacturing industry, arguing that the city is entitled to economic and health and welfare damages due to the ongoing opioid crisis.
“This lawsuit will seek to recover costs and tax resources taken from the City and its citizens due to the bad acts of the manufacturers and distributors of opioids who caused this ongoing crisis,” said Robins Kaplan attorney Roman Silberfeld.
2018
Repackaged injectable-drug enforcement case
Federal authorities alleged that AmerisourceBergen subsidiaries repackaged injectable medicines, including pre-filled syringes, and engaged in related billing and marketing practices. The company entered civil and criminal resolutions and paid substantial penalties.